[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

High-intensity Focused Ultrasound (HIFU) Therapy Market by Application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

June 2018 | 135 pages | ID: H252970C0DBEN
Allied Market Research

US$ 5,370.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
High-intensity focused ultrasound (HIFU) is a precise medical procedure, which applies high-intensity focused ultrasound energy to locally heat and destroy damaged or diseased tissue through ablation.
In this therapy, ultrasound beams are focused on diseased tissue, and owing to the considerable energy deposition at the focus, temperature within the tissue can rise to levels from 65°C to 85°C, and destroy the diseased tissue by coagulation necrosis. The global HIFU therapy market was valued at $81,000 thousand in 2017, and is estimated to reach at $398,724 thousand by 2025, registering a CAGR of 21.8% from 2018 to 2025.
Upsurge in geriatric population, surge in prevalence of chronic disease such as cancer, and favorable regulatory scenario towards HIFU devices are the key factors that augment the growth of the global HIFU therapy market. Furthermore, rise in awareness for early disease diagnosis is expected to boost the market growth.
However, lack of skilled professionals and limitations associated with HIFU therapy are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand of HIFU devices are expected to provide new opportunities for the market players in future.
The HIFU market is segmented based on application and region. On the basis of application, the market is categorized into prostate cancer, uterine fibroids, neurological disorders, aesthetics, and others. Region wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global HIFU therapy market.
  • Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
  • A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS

By Application
  • Prostate Cancer
  • Uterine Fibroids
  • Neurological Disorders
  • Aesthetics
  • Others
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
The list of key players operating in this market includes:
  • Chongqing Haifu Medical Technology Co., Ltd.
  • EDAP TMS S.A.
  • SonaCare Medical, LLC
  • ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
  • Image Guided Therapy S.A.
  • INSIGHTEC Ltd.
  • Theraclion SA
  • Merz Pharmaceuticals GmbH (Ulthera, Inc.)
  • Profound Medical Corp.
  • Shanghai A&S Technology Development Co., Ltd.
The other players included in the value chain analysis (and not included in the report) include:
  • Sonic Concepts, Inc.
  • Mianyang Sonic Electronic Ltd.
  • FUS Instruments
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
  1.3.1. List of key players profiled in the report
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
  3.2.2. Top winning strategies
3.3. Top Player Positioning, 2017
3.4. Patent analysis, 2010-2018
  3.4.1. Patent analysis, by year (2010-2018)
  3.4.2. Patent analysis, by country
3.5. High-intensity focused ultrasound (HIFU): innovative products
  3.5.1. Focal-One
  3.5.2. Ulthera system
  3.5.3. Exablate Neuro
3.6. Market dynamics
  3.6.1. Drivers
    3.6.1.1. Favorable regulatory scenario
    3.6.1.2. Rise in awareness for early disease diagnosis
    3.6.1.3. Rapid increase in elderly population
  3.6.2. Restraints
    3.6.2.1. Limitations of HIFU therapy
    3.6.2.2. Dearth of skilled professionals
  3.6.3. Opportunity
    3.6.3.1. Untapped potential of the emerging economies

CHAPTER 4: HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY MARKET, BY APPLICATION

4.1. Overview
  4.1.1. Market size and forecast
4.2. Prostate cancer
  4.2.1. Market size and forecast
  4.2.2. Market analysis, by country
4.3. Uterine fibroids
  4.3.1. Market size and forecast
  4.3.2. Market analysis, by country
4.4. Neurological disorders
  4.4.1. Market size and forecast
  4.4.2. Market analysis, by country
4.5. Aesthetics
  4.5.1. Market size and forecast
  4.5.2. Market analysis, by country
4.6. Others
  4.6.1. Market size and forecast
  4.6.2. Market analysis, by country

CHAPTER 5: HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY REGION

5.1. Overview
  5.1.1. Market size and forecast
5.2. North America
  5.2.1. Key market trends, growth factors, and opportunities
  5.2.2. North America HIFU market size and forecast, by country
    5.2.2.1. U.S. market size and forecast
    5.2.2.2. Canada market size and forecast
    5.2.2.3. Mexico market size and forecast
  5.2.3. North America HIFU market size and forecast, by Application
  5.2.4. North America HIFU market size and forecast, by Industry
5.3. Europe
  5.3.1. Key market trends, growth factors and opportunities
  5.3.2. Europe HIFU market size and forecast, by country
    5.3.2.1. Germany market size and forecast
    5.3.2.2. France market size and forecast
    5.3.2.3. UK market size and forecast
    5.3.2.4. Italy market size and forecast
    5.3.2.5. Spain market size and forecast
    5.3.2.6. Rest of Europe market size and forecast
  5.3.3. Europe HIFU market size and forecast, by Application
5.4. Asia-Pacific
  5.4.1. Key market trends, growth factors and opportunities
  5.4.2. Asia-Pacific HIFU market size and forecast, by country
    5.4.2.1. Japan market size and forecast
    5.4.2.2. China market size and forecast
    5.4.2.3. India market size and forecast
    5.4.2.4. Australia market size and forecast
    5.4.2.5. South Korea market size and forecast
    5.4.2.6. Rest of Asia-Pacific market size and forecast
  5.4.3. Asia-Pacific HIFU market size and forecast, by Application
5.5. LAMEA
  5.5.1. Key market trends, growth factors and opportunities
  5.5.2. LAMEA HIFU market size and forecast, by country
    5.5.2.1. Brazil market size and forecast
    5.5.2.2. Saudi Arabia market size and forecast
    5.5.2.3. South Africa market size and forecast
    5.5.2.4. Rest of LAMEA market size and forecast
  5.5.3. LAMEA HIFU market size and forecast, by Application

CHAPTER 6:

6.1. Chongqing Haifu Medical Technology Co., Ltd.
  6.1.1. Company overview
  6.1.2. Company snapshot
  6.1.3. Product portfolio
  6.1.4. Key strategic moves and developments
6.2. EDAP TMS S.A.
  6.2.1. Company overview
  6.2.2. Company snapshot
  6.2.3. Operating business segments
  6.2.4. Product portfolio
  6.2.5. Business performance
  6.2.6. Key strategic moves and developments
6.3. ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
  6.3.1. Company overview
  6.3.2. Company snapshot
  6.3.3. Product portfolio
6.4. Merz Pharmaceuticals GmbH (Ulthera, Inc.)
  6.4.1. Company overview
  6.4.2. Company snapshot
  6.4.3. Product portfolio
6.5. Theraclion SA
  6.5.1. Company overview
  6.5.2. Company snapshot
  6.5.3. Business performance
  6.5.4. Product portfolio
  6.5.5. Key strategic moves and developments
6.6. Image Guided Therapy S.A.
  6.6.1. Company overview
  6.6.2. Company snapshot
  6.6.3. Product portfolio
6.7. INSIGHTEC Ltd.
  6.7.1. Company overview
  6.7.2. Company snapshot
  6.7.3. Product portfolio
6.8. Profound Medical Corp.
  6.8.1. Company overview
  6.8.2. Company snapshot
  6.8.3. Product portfolio
  6.8.4. Key strategic moves and developments
6.9. SonaCare Medical, LLC.
  6.9.1. Company overview
  6.9.2. Company snapshot
  6.9.3. Product portfolio
6.10. Shanghai A&S Technology Development Co., Ltd.
  6.10.1. Company overview
  6.10.2. Company snapshot
  6.10.3. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL HIFU THERAPY MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 02. HIFU THERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2017-2025 ($THOUSAND)
TABLE 03. HIFU THERAPY MARKET FOR UTERINE FIBROIDS, BY REGION, 2017-2025 ($THOUSAND)
TABLE 04. HIFU THERAPY MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2017-2025 ($THOUSAND)
TABLE 05. HIFU THERAPY MARKET FOR AESTHETCS, BY REGION, 2017-2025 ($THOUSAND)
TABLE 06. HIFU THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($THOUSAND)
TABLE 07. HIFU MARKET REVENUE, BY REGION, 2017-2025 ($THOUSAND)
TABLE 08. NORTH AMERICA HIFU MARKET, BY COUNTRY, 2017-2025 ($THOUSAND)
TABLE 09. U.S. HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 10. CANADA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 11. MEXICO HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 12. NORTH AMERICA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 13. EUROPE HIFU MARKET, BY COUNTRY, 2017-2025 ($THOUSAND)
TABLE 14. GERMANY HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 15. FRANCE HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 16. UK HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 17. ITALY HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 18. SPAIN HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 19. REST OF EUROPE HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 20. EUROPE HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 21. ASIA-PACIFIC HIFU MARKET, BY COUNTRY, 2017-2025 ($THOUSAND)
TABLE 22. JAPAN HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 23. CHINA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 24. INDIA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 25. AUSTRALIA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 26. SOUTH KOREA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 27. REST OF ASIA-PACIFIC HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 28. ASIA-PACIFIC HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 29. LAMEA HIFU MARKET, BY COUNTRY, 2017-2025 ($THOUSAND)
TABLE 30. BRAZIL HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 31. SAUDI ARABIA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 32. SOUTH AFRICA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 33. REST OF LAMEA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 34. LAMEA HIFU MARKET, BY APPLICATION, 2017-2025 ($THOUSAND)
TABLE 35. HAIFU: COMPANY SNAPSHOT
TABLE 36. HAIFU: PRODUCT PORTFOLIO
TABLE 37. EDAP TMS: COMPANY SNAPSHOT
TABLE 38. EDAP TMS: OPERATING SEGMENTS
TABLE 39. EDAP TMS: PRODUCT PORTFOLIO
TABLE 40. ILJIN: COMPANY SNAPSHOT
TABLE 41. ALPINION: PRODUCT PORTFOLIO
TABLE 42. MERZ: COMPANY SNAPSHOT
TABLE 43. MERZ: PRODUCT PORTFOLIO
TABLE 44. THERACLION: COMPANY SNAPSHOT
TABLE 45. THERACLION: PRODUCT PORTFOLIO
TABLE 46. IGT: COMPANY SNAPSHOT
TABLE 47. IGT: PRODUCT PORTFOLIO
TABLE 48. INSIGHTEC: COMPANY SNAPSHOT
TABLE 49. INSIGHTEC: PRODUCT PORTFOLIO
TABLE 50. PROFOUND: COMPANY SNAPSHOT
TABLE 51. PROFOUND: PRODUCT PORTFOLIO
TABLE 52. SONACARE MEDICAL: COMPANY SNAPSHOT
TABLE 53. SONACARE MEDICAL: PRODUCT PORTFOLIO
TABLE 54. A&S: COMPANY SNAPSHOT
TABLE 55. A&S: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. PATENT REGISTERED/APPROVED, BY YEAR
FIGURE 08. PATENT REGISTERED, BY COUNTRY
FIGURE 09. IMPACT ANALYSES
FIGURE 10. ELDERLY POPULATION (AGED 65 AND ABOVE), BY GEOGRAPHY, 2015, 2030, AND 2050
FIGURE 11. COMPARATIVE REGION ANALYSIS OF HIFU THERAPY MARKET FOR PROSTATE CANCER, 2017 AND 2025 (%)
FIGURE 12. COMPARATIVE REGION ANALYSIS OF HIFU THERAPY MARKET FOR UTERINE FIBROIDS, 2017 AND 2025 (%)
FIGURE 13. COMPARATIVE REGION ANALYSIS OF HIFU THERAPY MARKET FOR NEUROLOGICAL DISORDERS, 2017 AND 2025 (%)
FIGURE 14. COMPARATIVE REGION ANALYSIS OF HIFU THERAPY MARKET FOR AESTHETICS, 2017 AND 2025 (%)
FIGURE 15. COMPARATIVE REGION ANALYSIS OF HIFU THERAPY MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 (%)
FIGURE 16. EDAP TMS: NET SALES, 2015-2017 ($MILLION)
FIGURE 17. EDAP TMS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 18. THERACLION: NET SALES, 2015-2017 ($MILLION)


More Publications